Structural and functional characterization of the product of disease-related factor H gene conversion

Biochemistry

Volumn 51, Issue 9, 2012, Pages 1874-1884

  Herbert, Andrew P ^a   Kavanagh, David ^a,c   Johansson, Conny ^a   Morgan, Hugh P ^b   Blaum, Bärbel S ^a,d   Hannan, Jonathan P ^b,e   Barlow, Paul N ^a,b   Uhrín, Dušan ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C-TERMINUS; CHONDROITIN SULFATES; CONFORMATIONAL RIGIDITY; DERMATAN; DOUBLE MUTATION; DOUBLE SUBSTITUTION; FUNCTIONAL CHARACTERIZATION; GENE CONVERSION; GLYCOSAMINOGLYCANS; HIGHER-DEGREE; MUTANT PROTEINS; POLYANIONICS; SELF-ASSOCIATIONS; WILD TYPES;

ASSOCIATION REACTIONS; ENCODING (SYMBOLS); RECOMBINANT PROTEINS;

GENE ENCODING;

COMPLEMENT FACTOR H; FH19 PROTEIN; FH20 PROTEIN; GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CARBOXY TERMINAL SEQUENCE; CRYSTALLIZATION; GEL FILTRATION CHROMATOGRAPHY; GENE CONVERSION; GENE MUTATION; GENETIC PREDISPOSITION; HEMOLYTIC UREMIC SYNDROME; HETERONUCLEAR SINGLE QUANTUM COHERENCE; ISOTHERMAL TITRATION CALORIMETRY; NITROGEN NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

COMPLEMENT C3B; COMPLEMENT C3D; COMPLEMENT FACTOR H; CRYSTALLOGRAPHY, X-RAY; GENE CONVERSION; HUMANS; MUTATION; PICHIA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 84857828404     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi201689j     Document Type: Article

References (61)

1. Ripoche, J., Day, A. J., Harris, T. J., and Sim, R. B. (1988) The complete amino acid sequence of human complement factor H Biochem. J. 249, 593-602
2. Schmidt, C. Q., Herbert, A. P., Hocking, H. G., Uhrin, D., and Barlow, P. N. (2008) Translational Mini-Review Series on Complement Factor H: Structural and functional correlations for factor H Clin. Exp. Immunol. 151, 14-24
3. Pangburn, M. K., Schreiber, R. D., and Muller-Eberhard, H. J. (1977) Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution J. Exp. Med. 146, 257-270
4. Lachmann, P. J. (2009) The amplification loop of the complement pathways Adv. Immunol. 104, 115-149
5. Walport, M. J. (2001) Complement. Second of two parts N. Engl. J. Med. 344, 1140-1144
6. Walport, M. J. (2001) Complement. First of two parts N. Engl. J. Med. 344, 1058-1066
7. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J. D. (2010) Complement: A key system for immune surveillance and homeostasis Nat. Immunol. 11, 785-797
8. Meri, S. and Pangburn, M. K. (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: Regulation via a sialic acid/polyanion binding site on factor H Proc. Natl. Acad. Sci. U.S.A. 87, 3982-3986
9. Jokiranta, T. S., Zipfel, P. F., Hakulinen, J., Kuhn, S., Pangburn, M. K., Tamerius, J. D., and Meri, S. (1996) Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: Evidence for multiple interactions between H and surface bound C3b FEBS Lett. 393, 297-302
10. Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., and Pangburn, M. K. (2006) Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces J. Immunol. 177, 6308-6316
11. Liszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A., and Atkinson, J. P. (1996) Control of the complement system Adv. Immunol. 61, 201-283
12. Kirkitadze, M. D. and Barlow, P. N. (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation Immunol. Rev. 180, 146-161
13. de Cordoba, S. R. and de Jorge, E. G. (2008) Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H Clin. Exp. Immunol. 151, 1-13
14. Buddles, M. R., Donne, R. L., Richards, A., Goodship, J., and Goodship, T. H. (2000) Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome Am. J. Hum. Genet. 66, 1721-1722
15. Saunders, R. E., Abarrategui-Garrido, C., Fremeaux-Bacchi, V., Goicoechea de Jorge, E., Goodship, T. H., Lopez Trascasa, M., Noris, M., Ponce Castro, I. M., Remuzzi, G., Rodriguez de Cordoba, S., Sanchez-Corral, P., Skerka, C., Zipfel, P. F., and Perkins, S. J. (2007) The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: Update and integration of membrane cofactor protein and Factor I mutations with structural models Hum. Mutat. 28, 222-234
16. Kavanagh, D. and Goodship, T. (2010) Genetics and complement in atypical HUS Pediatr. Nephrol. 25, 2431-2442
17. Gordon, D. L., Kaufman, R. M., Blackmore, T. K., Kwong, J., and Lublin, D. M. (1995) Identification of complement regulatory domains in human factor H J. Immunol. 155, 348-356
18. Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., and Goodship, T. H. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am. J. Hum. Genet. 68, 485-490
19. Pangburn, M. K. (2002) Cutting edge: Localization of the host recognition functions of complement factor H at the carboxyl-terminal: Implications for hemolytic uremic syndrome J. Immunol. 169, 4702-4706
20. Nan, R., Gor, J., and Perkins, S. J. (2008) Implications of the progressive self-association of wild-type human factor H for complement regulation and disease J. Mol. Biol. 375, 891-900
21. Pangburn, M. K., Rawal, N., Cortes, C., Alam, M. N., Ferreira, V. P., and Atkinson, M. A. (2009) Polyanion-induced self-association of complement factor H J. Immunol. 182, 1061-1068
22. Schmidt, C. Q., Herbert, A. P., Kavanagh, D., Gandy, C., Fenton, C. J., Blaum, B. S., Lyon, M., Uhrin, D., and Barlow, P. N. (2008) A new map of glycosaminoglycan and C3b binding sites on factor H J. Immunol. 181, 2610-2619
23. Morgan, H. P., Schmidt, C. Q., Guariento, M., Blaum, B. S., Gillespie, D., Herbert, A. P., Kavanagh, D., Mertens, H. D., Svergun, D. I., Johansson, C. M., Uhrin, D., Barlow, P. N., and Hannan, J. P. (2011) Structural basis for engagement by complement factor H of C3b on a self surface Nat. Struct. Mol. Biol. 18, 463-470
24. Ferreira, V. P., Herbert, A. P., Cortes, C., McKee, K. A., Blaum, B. S., Esswein, S. T., Uhrin, D., Barlow, P. N., Pangburn, M. K., and Kavanagh, D. (2009) The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome J. Immunol. 182, 7009-7018
25. Giannakis, E., Jokiranta, T. S., Male, D. A., Ranganathan, S., Ormsby, R. J., Fischetti, V. A., Mold, C., and Gordon, D. L. (2003) A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein Eur. J. Immunol. 33, 962-969
26. Herbert, A. P., Deakin, J. A., Schmidt, C. Q., Blaum, B. S., Egan, C., Ferreira, V. P., Pangburn, M. K., Lyon, M., Uhrin, D., and Barlow, P. N. (2007) Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism J. Biol. Chem. 282, 18960-18968
27. Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrin, D., Barlow, P. N., Sim, R. B., Day, A. J., and Lea, S. M. (2007) Structural basis for complement factor H-linked age-related macular degeneration J. Exp. Med. 204, 2277-2283
28. Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., Smith, R. J., Silvestri, G., Russell, S. R., Klaver, C. C., Barbazetto, I., Chang, S., Yannuzzi, L. A., Barile, G. R., Merriam, J. C., Smith, R. T., Olsh, A. K., Bergeron, J., Zernant, J., Merriam, J. E., Gold, B., Dean, M., and Allikmets, R. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Proc. Natl. Acad. Sci. U.S.A. 102, 7227-7232
29. Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., and Farrer, L. A. (2005) Complement factor H polymorphism and age-related macular degeneration Science 308, 421-424
30. Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., Schnetz-Boutaud, N., Agarwal, A., Postel, E. A., and Pericak-Vance, M. A. (2005) Complement factor H variant increases the risk of age-related macular degeneration Science 308, 419-421
31. Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J. Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., Bracken, M. B., Ferris, F. L., Ott, J., Barnstable, C., and Hoh, J. (2005) Complement factor H polymorphism in age-related macular degeneration Science 308, 385-389
32. Schmidt, C. Q., Herbert, A. P., Mertens, H. D., Guariento, M., Soares, D. C., Uhrin, D., Rowe, A. J., Svergun, D. I., and Barlow, P. N. (2010) The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module J. Mol. Biol. 395, 105-122
33. Jozsi, M. and Zipfel, P. F. (2008) Factor H family proteins and human diseases Trends Immunol. 29, 380-387
34. Zipfel, P. F., Edey, M., Heinen, S., Jozsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A. E., Goodship, J. A., Licht, C., Goodship, T. H., and Skerka, C. (2007) Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome PLoS Genet. 3, e41
35. Heinen, S., Sanchez-Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K., Wagner, E., Robitaille, P., Esparza-Gordillo, J., Rodriguez de Cordoba, S., Zipfel, P. F., and Goodship, T. H. (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome Hum. Mutat. 27, 292-293
36. Jokiranta, T. S., Jaakola, V. P., Lehtinen, M. J., Parepalo, M., Meri, S., and Goldman, A. (2006) Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome EMBO J. 25, 1784-1794
37. Heinen, S., Sanchez-Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K., Wagner, E., Robitaille, P., Esparza-Gordillo, J., Rodriguez de Cordoba, S., Zipfel, P. F., and Goodship, T. H. (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome Hum. Mutat. 27, 292-293
38. Heinen, S., Hartmann, A., Lauer, N., Wiehl, U., Dahse, H. M., Schirmer, S., Gropp, K., Enghardt, T., Wallich, R., Halbich, S., Mihlan, M., Schlotzer-Schrehardt, U., Zipfel, P. F., and Skerka, C. (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation Blood 114, 2439-2447
39. Shaw, C. D., Storek, M. J., Young, K. A., Kovacs, J. M., Thurman, J. M., Holers, V. M., and Hannan, J. P. (2010) Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking J. Mol. Biol. 404, 697-710
40. Young, K. A., Chen, X. S., Holers, V. M., and Hannan, J. P. (2007) Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21) J. Biol. Chem. 282, 36614-36625
41. Kavanagh, D., Burgess, R., Spitzer, D., Richards, A., Diaz-Torres, M. L., Goodship, J. A., Hourcade, D. E., Atkinson, J. P., and Goodship, T. H. (2007) The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation Mol. Immunol. 44, 3162-3167
42. Herbert, A. P., Uhrin, D., Lyon, M., Pangburn, M. K., and Barlow, P. N. (2006) Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure J. Biol. Chem. 281, 16512-16520
43. Vranken, W. F., Boucher, W., Stevens, T. J., Fogh, R. H., Pajon, A., Llinas, M., Ulrich, E. L., Markley, J. L., Ionides, J., and Laue, E. D. (2005) The CCPN data model for NMR spectroscopy: Development of a software pipeline Proteins 59, 687-696
44. Leslie, A. G. W. (1992) Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography, Daresbury Laboratory, Warrington, U.K.
45. Evans, P. (2006) Scaling and assessment of data quality Acta Crystallogr. D62, 72-82
46. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic software J. Appl. Crystallogr. 40, 658-674
47. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., and Terwilliger, T. C. (2002) PHENIX: Building new software for automated crystallographic structure determination Acta Crystallogr. D58, 1948-1954
48. Emsley, P. and Cowtan, K. (2004) Coot: Model-building tools for molecular graphics Acta Crystallogr. D60, 2126-2132
49. Painter, J. and Merritt, E. A. (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion Acta Crystallogr. D62, 439-450
50. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., III, Snoeyink, J., Richardson, J. S., and Richardson, D. C. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids Nucleic Acids Res. 35, W375-W383
51. Lo, M. C., Aulabaugh, A., Jin, G., Cowling, R., Bard, J., Malamas, M., and Ellestad, G. (2004) Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery Anal. Biochem. 332, 153-159
52. Lovatt, M., Cooper, A., and Camilleri, P. (1996) Energetics of cyclodextrin-induced dissociation of insulin Eur. Biophys. J. 24, 354-357
53. Kajander, T., Lehtinen, M. J., Hyvarinen, S., Bhattacharjee, A., Leung, E., Isenman, D. E., Meri, S., Goldman, A., and Jokiranta, T. S. (2011) Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement Proc. Natl. Acad. Sci. U.S.A. 108, 2897-2902
54. Kirkitadze, M. D., Krych, M., Uhrin, D., Dryden, D. T., Smith, B. O., Cooper, A., Wang, X., Hauhart, R., Atkinson, J. P., and Barlow, P. N. (1999) Independently melting modules and highly structured intermodular junctions within complement receptor type 1 Biochemistry 38, 7019-7031
55. Nan, R., Gor, J., Lengyel, I., and Perkins, S. J. (2008) Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease J. Mol. Biol. 384, 1341-1352
56. Diehl, C., Engstrom, O., Delaine, T., Hakansson, M., Genheden, S., Modig, K., Leffler, H., Ryde, U., Nilsson, U. J., and Akke, M. (2010) Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3 J. Am. Chem. Soc. 132, 14577-14589
57. Hocking, H. G., Herbert, A. P., Kavanagh, D., Soares, D. C., Ferreira, V. P., Pangburn, M. K., Uhrin, D., and Barlow, P. N. (2008) Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations J. Biol. Chem. 283, 9475-9487
58. Wu, J., Wu, Y. Q., Ricklin, D., Janssen, B. J., Lambris, J. D., and Gros, P. (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators Nat. Immunol. 10, 728-733
59. Pechtl, I. C., Kavanagh, D., McIntosh, N., Harris, C. L., and Barlow, P. N. (2011) Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities J. Biol. Chem. 286, 11082-11090
60. Tortajada, A., Montes, T., Martinez-Barricarte, R., Morgan, B. P., Harris, C. L., and de Cordoba, S. R. (2009) The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity Hum. Mol. Genet. 18, 3452-3461
61. Strobel, S., Abarrategui-Garrido, C., Fariza-Requejo, E., Seeberger, H., Sanchez-Corral, P., and Jozsi, M. (2011) Factor H-related protein 1 neutralizes anti-factor H autoantibodies in Kidney Int. 80, 397-404